Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells.
about
Clinical and experimental applications of sodium phenylbutyrateRegulation of connexin signaling by the epigenetic machineryExperimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer.Homo sapiens systemic RNA interference-defective-1 transmembrane family member 1 (SIDT1) protein mediates contact-dependent small RNA transfer and microRNA-21-driven chemoresistance.Cardiac cellular coupling and the spread of early instabilities in intracellular Ca2+.Current evidence for histone deacetylase inhibitors in pancreatic cancer.Targeting histone deacetylases in pancreatic ductal adenocarcinoma.The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.Gap junctions and connexins as therapeutic targets in cancer.Possible role of autophagy in the treatment of pancreatic cancer with histone deacetylase inhibitors.Cardiac to cancer: connecting connexins to clinical opportunity.Mechanisms linking connexin mutations to human diseases.Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line.The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.Ion channels in control of pancreatic stellate cell migration.Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer.Reduced microtubule acetylation in cystic fibrosis epithelial cells.Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.Reduction of endoplasmic reticulum stress by 4-phenylbutyric acid prevents the development of hypoxia-induced pulmonary arterial hypertension.
P2860
Q24613511-649997CC-C8C3-4937-B882-F1508C239BDCQ26777260-79B14B54-8BFE-440B-94E1-83C020A7BC65Q34297701-7084226D-8166-443C-A123-86CF84BDD2D3Q35773897-ED169779-7616-41FC-B1E8-E3D0F739FFCAQ35843505-822CB40A-3FE5-44E4-9689-B1BDE49920D7Q36616790-F38841CC-71B1-48BC-AAD3-03CDE56FDE26Q37310587-E505E960-C0EE-4A1E-9753-34F1E87364A1Q37641572-03082C85-F5BF-44F0-B553-EB268387B1F9Q37743527-213C3221-B070-4D4C-941F-137E2A462AD6Q38166587-49550876-29BA-4C86-A330-4B7310C66226Q38194340-69A2BEB6-6306-4D07-B5C8-27511A2C79F6Q38268356-2BDD36AC-2B09-4C2F-9892-A219D92F3D58Q38844777-0CD00FA6-D4DE-4CAD-AD67-8D1358FE0673Q40099844-22DB45D0-DC9B-428A-902E-87D90B7C5C4EQ42316196-6BD8EA83-E055-497D-AAB3-FEFE26BBB53CQ42362715-640D568C-40B2-4FB0-B0E9-0C56D97EE2FDQ42585054-668F2DB6-C7BF-4652-8C3A-EE354DE9DE4DQ47130359-982BE842-A12B-480E-8D3E-882D867E359BQ54370056-4AA617FD-345E-4534-823E-EDF81FCAAD3C
P2860
Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Complementary effects of HDAC ...... hemosensitivity of PDAC cells.
@en
type
label
Complementary effects of HDAC ...... hemosensitivity of PDAC cells.
@en
prefLabel
Complementary effects of HDAC ...... hemosensitivity of PDAC cells.
@en
P2093
P2860
P356
P1476
Complementary effects of HDAC ...... hemosensitivity of PDAC cells.
@en
P2093
A Trauzold
B Schniewind
H Kalthoff
H-D Saeger
O Ammerpohl
R Grutzmann
P2860
P2888
P356
10.1038/SJ.BJC.6603511
P407
P577
2006-12-12T00:00:00Z